Antheia

Science and technology company developing next generation plant-inspired medicines

Based in CA

🤖

AI Overview

With $1.1M in lobbying spend across 23 quarterly filings, Antheia is a significant lobbying presence. Their lobbying covers 2 issue areas. Active from 2020 to 2025.

$1.1M
Total Spend
6
Years Active
1
Firms Hired
6
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$120K
2021$240K
2022$240K
2023$240K
2024$240K
2025$0

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Defense

  • Issues related to the pharmaceutical supply chain.
  • Encourage support for technology solutions to shift the pharmaceutical supply chain back to the U.S.; highlight Antheia's use of synthetic biology to produce active pharmaceutical ingredients.
  • Highlight Antheia's use of synthetic biology to produce active pharmaceutical ingredients. Encourage support for federal loan programs for technology to strengthen our domestic supply chain for pharma

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.